255 related articles for article (PubMed ID: 38173286)
1. CD1a and skin T cells: a pathway for therapeutic intervention.
Ye JH; Chen YL; Ogg G
Clin Exp Dermatol; 2024 Apr; 49(5):450-458. PubMed ID: 38173286
[TBL] [Abstract][Full Text] [Related]
2. Filaggrin inhibits generation of CD1a neolipid antigens by house dust mite-derived phospholipase.
Jarrett R; Salio M; Lloyd-Lavery A; Subramaniam S; Bourgeois E; Archer C; Cheung KL; Hardman C; Chandler D; Salimi M; Gutowska-Owsiak D; de la Serna JB; Fallon PG; Jolin H; Mckenzie A; Dziembowski A; Podobas EI; Bal W; Johnson D; Moody DB; Cerundolo V; Ogg G
Sci Transl Med; 2016 Feb; 8(325):325ra18. PubMed ID: 26865566
[TBL] [Abstract][Full Text] [Related]
3. Down-regulation of Langerhans cell protein kinase C-beta isoenzyme expression in inflammatory and hyperplastic dermatoses.
Reynolds NJ; Yi JY; Fisher GJ; Cooper KD; Voorhees JJ; Griffiths CE
Br J Dermatol; 1995 Aug; 133(2):157-67. PubMed ID: 7547380
[TBL] [Abstract][Full Text] [Related]
4. CD1a and bound lipids drive T-cell responses in human skin disease.
Ogg GS; Rossjohn J; Clark RA; Moody DB
Eur J Immunol; 2023 Oct; 53(10):e2250333. PubMed ID: 37539748
[TBL] [Abstract][Full Text] [Related]
5. Current Understanding of the Roles of CD1a-Restricted T Cells in the Immune System.
Yoo HJ; Kim NY; Kim JH
Mol Cells; 2021 May; 44(5):310-317. PubMed ID: 33980746
[TBL] [Abstract][Full Text] [Related]
6. Staphylococcal phosphatidylglycerol antigens activate human T cells via CD1a.
Monnot GC; Wegrecki M; Cheng TY; Chen YL; Sallee BN; Chakravarthy R; Karantza IM; Tin SY; Khaleel AE; Monga I; Uwakwe LN; Tillman A; Cheng B; Youssef S; Ng SW; Shahine A; Garcia-Vilas JA; Uhlemann AC; Bordone LA; Han A; Rohde CH; Ogg G; Moody DB; Rossjohn J; de Jong A
Nat Immunol; 2023 Jan; 24(1):110-122. PubMed ID: 36550321
[TBL] [Abstract][Full Text] [Related]
7. CD1a-mediated immunity from a molecular perspective.
Wegrecki M
Mol Immunol; 2023 Jun; 158():43-53. PubMed ID: 37116273
[TBL] [Abstract][Full Text] [Related]
8. Human T cell response to CD1a and contact dermatitis allergens in botanical extracts and commercial skin care products.
Nicolai S; Wegrecki M; Cheng TY; Bourgeois EA; Cotton RN; Mayfield JA; Monnot GC; Le Nours J; Van Rhijn I; Rossjohn J; Moody DB; de Jong A
Sci Immunol; 2020 Jan; 5(43):. PubMed ID: 31901073
[TBL] [Abstract][Full Text] [Related]
9. Epidermal Langerhans cells efficiently mediate CD1a-dependent presentation of microbial lipid antigens to T cells.
Peña-Cruz V; Ito S; Dascher CC; Brenner MB; Sugita M
J Invest Dermatol; 2003 Sep; 121(3):517-21. PubMed ID: 12925210
[TBL] [Abstract][Full Text] [Related]
10. Feline atopic dermatitis. A model for Langerhans cell participation in disease pathogenesis.
Roosje PJ; Whitaker-Menezes D; Goldschmidt MH; Moore PF; Willemse T; Murphy GF
Am J Pathol; 1997 Oct; 151(4):927-32. PubMed ID: 9327725
[TBL] [Abstract][Full Text] [Related]
11. Phospholipase activity of acyloxyacyl hydrolase induces IL-22-producing CD1a-autoreactive T cells in individuals with psoriasis.
Singh R; Chen YL; Ng SW; Cain D; Etherington R; Hardman C; Ogg G
Eur J Immunol; 2022 Mar; 52(3):511-524. PubMed ID: 34913478
[TBL] [Abstract][Full Text] [Related]
12. Cutting Edge: CD1a tetramers and dextramers identify human lipopeptide-specific T cells ex vivo.
Kasmar AG; Van Rhijn I; Magalhaes KG; Young DC; Cheng TY; Turner MT; Schiefner A; Kalathur RC; Wilson IA; Bhati M; Gras S; Birkinshaw RW; Tan LL; Rossjohn J; Shires J; Jakobsen S; Altman JD; Moody DB
J Immunol; 2013 Nov; 191(9):4499-503. PubMed ID: 24089190
[TBL] [Abstract][Full Text] [Related]
13. CD1a on Langerhans cells controls inflammatory skin disease.
Kim JH; Hu Y; Yongqing T; Kim J; Hughes VA; Le Nours J; Marquez EA; Purcell AW; Wan Q; Sugita M; Rossjohn J; Winau F
Nat Immunol; 2016 Oct; 17(10):1159-66. PubMed ID: 27548435
[TBL] [Abstract][Full Text] [Related]
14. The ICAM-3/LFA-1 interaction is critical for epidermal Langerhans cell alloantigen presentation to CD4+ T cells.
Griffiths CE; Railan D; Gallatin WM; Cooper KD
Br J Dermatol; 1995 Dec; 133(6):823-9. PubMed ID: 8547030
[TBL] [Abstract][Full Text] [Related]
15. Lipid-specific T cells and the skin.
Jarrett R; Ogg G
Br J Dermatol; 2016 Oct; 175 Suppl 2():19-25. PubMed ID: 27667311
[TBL] [Abstract][Full Text] [Related]
16. Hyperstimulatory CD1a+CD1b+CD36+ Langerhans cells are responsible for increased autologous T lymphocyte reactivity to lesional epidermal cells of patients with atopic dermatitis.
Taylor RS; Baadsgaard O; Hammerberg C; Cooper KD
J Immunol; 1991 Dec; 147(11):3794-802. PubMed ID: 1719088
[TBL] [Abstract][Full Text] [Related]
17. Contact sensitizers trigger human CD1-autoreactive T-cell responses.
Betts RJ; Perkovic A; Mahapatra S; Del Bufalo A; Camara K; Howell AR; Martinozzi Teissier S; De Libero G; Mori L
Eur J Immunol; 2017 Jul; 47(7):1171-1180. PubMed ID: 28440548
[TBL] [Abstract][Full Text] [Related]
18. Functional CD86 (B7-2/B70) is predominantly expressed on Langerhans cells in atopic dermatitis.
Ohki O; Yokozeki H; Katayama I; Umeda T; Azuma M; Okumura K; Nishioka K
Br J Dermatol; 1997 Jun; 136(6):838-45. PubMed ID: 9217814
[TBL] [Abstract][Full Text] [Related]
19. Immunomorphological and ultrastructural characterization of Langerhans cells and a novel, inflammatory dendritic epidermal cell (IDEC) population in lesional skin of atopic eczema.
Wollenberg A; Kraft S; Hanau D; Bieber T
J Invest Dermatol; 1996 Mar; 106(3):446-53. PubMed ID: 8648175
[TBL] [Abstract][Full Text] [Related]
20. CD1a presentation of endogenous antigens by group 2 innate lymphoid cells.
Hardman CS; Chen YL; Salimi M; Jarrett R; Johnson D; Järvinen VJ; Owens RJ; Repapi E; Cousins DJ; Barlow JL; McKenzie ANJ; Ogg G
Sci Immunol; 2017 Dec; 2(18):. PubMed ID: 29273672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
